NASDAQ:SPK SPK Acquisition (SPK) Earnings Date, Estimates & Call Transcripts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$10.16▼$10.3052-Week Range N/AVolume33,500 shsAverage Volume12,839 shsMarket Capitalization$67.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A EarningsProfileEarningsFinancialsInstitutional OwnershipSEC FilingsShort InterestSocial MediaProfileEarningsFinancialsInstitutional OwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSPK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SPK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.SPK Acquisition Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/14/2022Q3 2022($0.01)($0.01)($0.01)8/15/2022Q2 2022($0.02)($0.02)($0.02)5/17/2022Q1 2022($0.07)($0.07)($0.07)11/15/2021Q3 2021($0.20)($0.20)($0.20)SPK Acquisition Earnings - Frequently Asked Questions How much profit does SPK Acquisition generate each year? SPK Acquisition (NASDAQ:SPK) has a recorded net income of -$420,000.00. SPK has generated $0.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Black Diamond Therapeutics Earnings Date MiNK Therapeutics Earnings Date Dyadic International Earnings Date TCR2 Therapeutics Earnings Date Cardiff Oncology Earnings Date Cognition Therapeutics Earnings Date TScan Therapeutics Earnings Date Curis Earnings Date Quince Therapeutics Earnings Date Passage Bio Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Trading Channel Breakout in Lululemon Brought by EarningsNordstrom's Earnings Beat, A Rally In The MakingMacy's Stock Earnings, A Pivotal StoryC3.AI's Lukewarm Earnings: Failing to Cash in on AI Boom?NetApp Is Gearing Up To Breakout After Earnings Top EstimatesWhat U-Haul Earnings Are Showing, Heading Up?Can Earnings Narrow The Value Gap In Hewlett Packard? This page (NASDAQ:SPK) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPK Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.